Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT07055828

Nebulized vs. IV Ketamine in Preventing Shivering Post Spinal Anesthesia

Nebulized Versus Intravenous Ketamine as Prophylaxis Against Spinal Anesthesia-induced Shivering and Hemodynamic Changes: A Placebo-controlled Prospective Study

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
120 (actual)
Sponsor
Tanta University · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Shivering is an involuntary muscle activity, often triggered by hypothermia, that can occur after anesthesia. This is known as postanesthetic shivering (PAS) and is a common issue that increases oxygen demand, raises the risk of low oxygen levels, and can lead to complications after surgery. Spinal anesthesia (SA) is a popular choice due to its quick action and effective numbing. However, it's frequently linked to shivering during and after the procedure. To combat PAS, various methods have been used. Non-pharmacological approaches like insulation, continuous warming, and temperature management have been shown to reduce low body temperature during surgery and decrease shivering and complications afterward, aiding recovery. Pharmacologically, certain medications can help. Intrathecal meperidine or intravenous (IV) ketamine are effective in preventing PAS. Intrathecal midazolam can also reduce shivering, unlike fentanyl. Additionally, IV ketamine infusion can lower the incidence of low blood pressure and shivering in patients receiving SA. Low-dose ketamine combined with dexmedetomidine, or dexmedetomidine alone, have also shown similar effectiveness in reducing shivering and postoperative nausea and vomiting during SA.

Conditions

Interventions

TypeNameDescription
DRUGKetaminePatients received IV ketamine 0.25 mg/kg before Spinal anesthesia as a prophylactic drug
DRUGIntranasal ketaminePatients received nebulized ketamine at a dose of 0.75 mg/kg adjusted to 5 ml by adding normal saline to be inhaled through a breath-actuated nebulizer
DRUGNormal SalinePatients received Intravenous Normal saline
DRUGSaline InhalantsPatients received nebulized Saline

Timeline

Start date
2025-05-02
Primary completion
2025-06-27
Completion
2025-07-15
First posted
2025-07-09
Last updated
2025-07-09

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT07055828. Inclusion in this directory is not an endorsement.